Factores asociados a mastopatía quística difusa en pacientes con obesidad mórbida de 35-45 años ingresados a hospitalización del Hospital Naval General de Guayaquil; período 2017- 2021.

Abstract

The breast is a pair of glandular organs that are part of a woman's femininity and that constantly change in shape, size and anatomy over time. The breasts are also considered the main means by which a woman should nurse her child after childbirth. However, being an organ made up of fibrous and adipose tissue, complemented by a system of ducts that connect the mammary gland, it is subject to various pathologies that it can develop. The objective is to establish the prevalence of diffuse cystic mastopathy in morbidly obese patients aged 35-45 years admitted to hospitalization at the General Naval Hospital of Guayaquil for the period 2017-2021. The methodology was a cross-sectional study with a retrospective, correlational approach and analysis of the information through an observational descriptive model, in addition the information was analyzed through the statistical program IBM SPSS Statistics. Similarly, Pearson's correlative tests have been used to determine the appropriate correlation. of obesity as the main complication of diffuse cystic mastopathy, likewise the population were the patients treated at the General Naval Hospital of Guayaquil with a diagnosis of diffuse cystic mastopathy, the total number of patients evaluated was 237. Results can be evidenced hypercaloric diets ( 43.5%); sedentary lifestyle (52.7%); gynecological-obstetric history in patients with two previous pregnancies (33.8%); family history (31.1%) and morbid obesity (100%), in addition, the most prevalent mastopathy was Type I, meaning 65.8%, while in relation to obesity as the main complication of diffuse cystic mastopathy, a correlation was demonstrated high positive between diffuse cystic mastopathy and obesity, therefore, obesity was directly related as the main complication of the pathology in patients aged 35-45. It is concluded that the highest prevalence of diffuse cystic mastopathy was evidenced in 2019, meaning 35 .9% of the annual prevalences during 2017 to 2021.